(2022) found that interventions such as microwave ablation in NSCLC patients can alter systemic cytokine profiles particularly IL-2 and IFN-γ, indicating a shift in immune status post-treatment (14). The gene discussed is IL2; the disease is non-small cell lung carcinoma.